B1Q

F:B1Q Germany Biotechnology
Market Cap
$51.36 Million
€50.03 Million EUR
Market Cap Rank
#22784 Global
#2475 in Germany
Share Price
€1.69
Change (1 day)
-8.65%
52-Week Range
€1.40 - €2.16
All Time High
€2.16
Categories
Companies in Germany Biotechnology
About

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in p… Read more

B1Q (B1Q) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.112x

Based on the latest financial reports, B1Q (B1Q) has a cash flow conversion efficiency ratio of 0.112x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.89 Million) by net assets (€-25.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

B1Q - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how B1Q's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

B1Q Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of B1Q ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ten Ren Tea Co Ltd
TW:1233
 		0.036x
Ramssol Group Bhd
KLSE:0236
 		0.140x
Daily Polymer
TWO:4716
 		0.024x
ImpediMed Limited
PINK:IPDQF
 		-0.390x
TGS Dis Ticaret AS
IS:TGSAS
 		-0.121x
Dmg Blockchain Solutions Inc
OTCQB:DMGGF
 		0.017x
Delta Lithium Ltd
AU:DLI
 		-0.007x
Aallon Group Oyj
HE:AALLON
 		0.051x

Annual Cash Flow Conversion Efficiency for B1Q (2021–2024)

The table below shows the annual cash flow conversion efficiency of B1Q from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-23.22 Million €-10.64 Million 0.458x -75.19%
2023-12-31 €-11.73 Million €-21.66 Million 1.846x +134.40%
2022-12-31 €7.41 Million €-39.76 Million -5.366x -196.10%
2021-12-31 €20.81 Million €-37.70 Million -1.812x --